Effectiveness of favipiravir in COVID-19 patients with risk factors for mortality: A real world experience from India.

S. Panchal (Mumbai, India), K. Venugopal (Chennai, India), A. Vora (Mumbai, India), A. Daxini (Mumbai, India), P. Dadhich (Ajmer, India), S. Bhagat (Mumbai, India), S. Patil (Mumbai, India), H. Barkate (Mumbai, India), S. Patil (Mumbai, India)

Source: Virtual Congress 2021 – COVID - 19 treatments
Session: COVID - 19 treatments
Session type: E-poster
Number: 3684

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Panchal (Mumbai, India), K. Venugopal (Chennai, India), A. Vora (Mumbai, India), A. Daxini (Mumbai, India), P. Dadhich (Ajmer, India), S. Bhagat (Mumbai, India), S. Patil (Mumbai, India), H. Barkate (Mumbai, India), S. Patil (Mumbai, India). Effectiveness of favipiravir in COVID-19 patients with risk factors for mortality: A real world experience from India.. 3684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Evaluation of risk factors for mortality among ARDS patients in Hyderabad, south India
Source: Eur Respir J 2007; 30: Suppl. 51, 581s
Year: 2007

Real world evaluation of asthma control risk factors and management: findings from China national asthma control surveys
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania
Source: Eur Respir J, 51 (2) 1700182; 10.1183/13993003.00182-2017
Year: 2018



Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019


Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data
Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019
Year: 2019



Late Breaking Abstract - Identifying preventable early risk factors for asthma in Indigenous children: a population cohort study in Western Australia.
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




Prevalence rate and risk factors for hospital readmissions for asthma in children and adolescents in a tropical setting
Source: Eur Respir J 2002; 20: Suppl. 38, 535s
Year: 2002

Epidemiology of COVID-19: global spread, risk factors for disease incidence, severity and mortality
Source: Eur Respir Monogr 2021; 94: 14-27
Year: 2021


PARFAIT (Prevalence and risk factors of allergies in Turkey) study: results of adults
Source: Eur Respir J 2006; 28: Suppl. 50, 241s
Year: 2006

The results of the TB control during of it epidemic in Ukraine on the base of the TB incidence in risk groups studying
Source: Eur Respir J 2003; 22: Suppl. 45, 518s
Year: 2003

Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



The clinical features and the risk factors of teenagers cases with MDR-TB in Romania
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
Source: Eur Respir J, 50 (3) 1700644; 10.1183/13993003.00644-2017
Year: 2017



Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP?
Source: Eur Respir J 2004; 23: 103-105
Year: 2004



Interventions and service models for the people most at risk of tuberculosis, including refugees
Source: International Congress 2016 – Respiratory infectious disease control in Europe
Year: 2016


Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016



Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Qualitative phenomenological study informs the development of educational intervention for behaviour change to reduce morbidity and mortality in adults with chronic lung disease in rural India
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Smoking is a risk factor for TB infection, but is it an additional mortality risk?
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011